Puig Shares Tumble After Estée Lauder Walks Away From Merger Talks

Puig Brands shares fell sharply on the news that merger discussions with Estée Lauder have been terminated. The stock declined 13.9% to trade at 15.19 after both companies confirmed they had ended talks that began in March 2026 and were publicly disclosed on March 23, 2026. The companies announced the termination of the discussions on May 21.

The potential combination would have assembled a roughly $40 billion luxury beauty group, bringing together Este9e Lauder-owned labels such as Tom Ford, Clinique and MAC with Puigb9s portfolio that includes Carolina Herrera and Charlotte Tilbury. Market participants reacted asymmetrically to the collapse of negotiations - Este9e Lauder shares rose while Puig's shares plunged.

Este9e Lauder said it was "grateful for the conversations we have had with Puig. Today, we are reiterating our confidence in the power of our incredible brands, our talented teams, and our strength as a stand-alone company." Este9e Lauder shares rose over 10% in extended trading on Thursday as investors welcomed the end of a proposed deal that analysts had flagged for adding integration risk, placing strain on the acquirer's balance sheet and potentially diverting management focus from an ongoing turnaround plan.

Reports surrounding the talks indicated the process was already complex. When details leaked in the Spanish press and the two companies were compelled to confirm that they were negotiating in March, the public disclosure increased the difficulty of progressing toward a transaction. The situation was further complicated when Charlotte Tilbury, the founder of the makeup brand owned by Puig, engaged an adviser and began renegotiating her contract with Puig. That contract renegotiation became a sticking point that was described as hard to resolve.

RBC Capital Markets analyst Nik Modi said he felt "relieved" the talks had concluded. He added: "We continue to believe that [Este9e Lauder's] underlying story has meaningful momentum and integration risk of a potential combination would have weighed on the stock for an extended period of time." His comments underscore concerns that a merger could have created prolonged integration challenges and uncertainty for investors.

The market reaction underscored a prevailing view that Puig stood to benefit most from a strategic combination, hence the particularly negative response in Puigb9s share price and a more positive reaction for Este9e Lauder. The broader Spanish market offered little support - the IBEX 35 traded in a narrow range on the day, providing no macro tailwind to offset the company-specific shock to Puigb9s valuation.

Puig has been contending with downward pressure since its initial public offering in May 2024, and the latest move pushed the stock closer to the lower bound of its 52-week range of 13.11 to 18.89. The combination of a failed transformative deal, an already pressured share price and a neutral market backdrop produced one of the sharpest single-session declines in PUIGb's short listed history.

Summary

• Puig shares fell 13.9% to 15.19 after confirming the end of merger talks with Este9e Lauder.
• The proposed $40 billion luxury beauty combination would have combined brands such as Tom Ford, Clinique and MAC with Puig labels including Carolina Herrera and Charlotte Tilbury.
• Este9e Lauder shares rose in extended trading as investors favored the company remaining independent amid concerns about integration risk and balance-sheet pressure.

Key points

• Strategic outcome - The collapse of negotiations leaves both companies pursuing separate paths; markets viewed Puig as the party that stood to gain most from a combination.
• Equities impact - Este9e Lauder stock rallied more than 10% in extended hours, while Puig experienced a steep intraday drop, reflecting diverging investor sentiment.
• Market context - A neutral IBEX 35 provided no cushioning effect for Puig's stock reaction, amplifying the company-specific move in Spain's equity market.

Risks and uncertainties

• Integration risk - Analysts had warned a deal could add significant integration risk, potentially affecting operational focus and execution for the combined entity.
• Balance-sheet and management risk - Concerns were raised that a large acquisition could stretch Este9e Lauder's balance sheet and distract management from an ongoing turnaround.
• Contractual complications - Negotiations were hindered by Charlotte Tilbury's decision to hire an adviser and reopen contract terms with Puig, a factor that proved difficult to resolve.

The market reaction to the termination of talks illustrates how sensitive equity prices are to strategic deal outcomes and to company-specific operational complications. For Puig, the failure to reach an agreement coincided with existing downward pressure since its May 2024 IPO, leaving its stock nearer to the bottom of its recent trading range. For Este9e Lauder, ending the talks removed the potential integration and financing overhang that analysts had viewed as a threat to near-term progress on its standalone recovery plan.